Kolexia
Peytavin Gilles Pharmacien
Peytavin Gilles
Pharmacien
Hôpital Bichat-Claude-Bernard
Paris, France
289 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH Hépatite COVID-19 Hépatite C Infections à coronavirus Syndrome d'immunodéficience acquise Virémie Maladies transmissibles Co-infection

Collaborateurs

Voir plus
Calvez Vincent
Calvez Vincent
Hôpital Pitie Salpetriere, Paris, France
Katlama Christine
Katlama Christine
Hôpital Pitie Salpetriere, Paris, France
Descamps Diane
Descamps Diane
Hôpital Bichat-Claude-Bernard, Paris, France
Heliot-Marcelin Anne-Genevieve
Heliot-Marcelin Anne-Genevieve
Hôpital Pitie Salpetriere, Paris, France

Industries

Voir plus
Gilead
26 collaboration(s)
Dernière en 2023
MSD
21 collaboration(s)
Dernière en 2023
ViiV Healthcare
20 collaboration(s)
Dernière en 2023
CONGRES COLLOQUES CONVENTIONS
13 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Nirmatrelvir and Ritonavir combination in COVID-19 patients with advanced chronic kidney disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   30 décembre 2023
Letermovir for CMV Prophylaxis in Very High-Risk Pediatric Hematopoietic Stem Cell Transplantation Recipients for Inborn Errors of Immunity.
Journal of clinical immunology   20 décembre 2023
HIV viremias among patients who discontinued Cabotegravir (CAB)/Rilpivirine (RPV) Long acting (LA) intramuscular (IM) in real-life setting
HIV medicine Congress 2023   01 décembre 2023
Real-world data on commercial long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror phase 3 results: Findings from a University Hospital in Paris, France
HIV medicine Congress 2023   01 décembre 2023
Can we drug reduce antiretroviral regimen with dual NRTI regimen in naïve patients with viral load <50,000 copies/mL and CD4>300 cells/μL?: Results from a randomized non-inferiority ANRS 173 ALTAR trial
HIV medicine Congress 2023   01 décembre 2023
Penetration of doravirine combined to raltegravir in semen: Preliminary results of the DORAL switch study
HIV medicine Congress 2023   01 décembre 2023
DisCoVeRy: Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Essai Clinique (Institut National de la Santé Et de la Recherche Médicale, France)   24 novembre 2023
Proportion of APOBEC3-induced defective HIV DNA after 1 year of dolutegravir + lamivudine simplification in the ANRS 167 LAMIDOL trial.
The Journal of antimicrobial chemotherapy   01 novembre 2023
Nouveaux ARV : pharmacologie pour le clinicien
Edimark   31 août 2023
Human Immunodeficiency Virus Seroconversion Among Men Who Have Sex With Men Who Use Event-Driven or Daily Oral Pre-Exposure Prophylaxis (CohMSM-PrEP): A Multi-Country Demonstration Study From West Africa.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   24 août 2023